Beneficient (BENF) Common Equity (2021 - 2026)

Beneficient has disclosed Common Equity across 6 years of filings, most recently posting -$184.1 million for Q2 2026.

• In Q2 2026, Common Equity fell 52.9% year-over-year to -$184.1 million; the TTM figure through Jun 2026 stood at -$184.1 million (down 52.9% YoY), while the FY2026 annual figure was -$189.3 million, down 441.98% from the prior year.
• Common Equity came in at -$184.1 million for Q2 2026 at Beneficient, up from -$189.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.9 billion in Q1 2022 to a low of -$192.1 million in Q1 2024.
• Average Common Equity over 5 years is $493.7 million, with a median of $4.0 million recorded in 2023.
• Year-over-year, Common Equity jumped 258.92% in 2024 and sank 1001.59% in 2025.
• Over 5 years, Common Equity stood at $1.8 billion in 2022, then tumbled by 99.78% to $4.0 million in 2023, then jumped by 258.92% to $14.3 million in 2024, then slumped by 1001.59% to -$128.6 million in 2025, then sank by 43.19% to -$184.1 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$184.1 million in Q2 2026, -$189.3 million in Q1 2026, and -$128.6 million in Q4 2025.